EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Mild Neurodevelopmental Phenotype Associated with a Novel BRAT1 Variant: Expanding Genotype–Phenotype Correlations

Camilla Meossi iD, Lorenzo Cipriano iD, Flavio Dal Canto iD, Stefano Pagano iD, Giulia Nutile, Alessandra Tessa, Carla Cona, Gianmarco Dalla Zanna, Roberta Battini iD, Domenico Montanaro, Filippo M Santorelli iD

Medical Sciences · 2026

DOI: 10.3390/medsci14060641 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Medical Sciences, 2026. Verfasst von Camilla Meossi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Via dei Giacinti 2, 56128 Pisa, Italy. Hauptthemen laut MEDLINE: Genetic Association Studies, Cell Cycle Proteins, Neurodevelopmental Disorders, Nuclear Proteins. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

BRAT1-related disorders constitute a continuous neurodevelopmental spectrum ranging from rigidity and multifocal seizure syndrome, lethal neonatal form (RMFSL) to milder phenotypes characterized by cerebellar involvement and variable developmental impairment. Genotype–phenotype correlations remain incompletely defined, particularly for missense variants that may retain residual function.

Objectives

To characterize clinical and molecular findings in a patient with a mild BRAT1-related phenotype.

Methods

An 18-year-old boy underwent clinical, neuroradiological, neurophysiological, and genetic evaluations. Exome sequencing with in silico filtering on an ataxia gene panel and parental segregation analysis was performed. BRAT1 protein expression was assessed by Western blot analysis in patient-derived fibroblasts.

Results

We report an 18-year-old male carrying compound heterozygous BRAT1 variants, including a recurrent truncating variant (c.294dup) and a novel missense variant (c.1784A>T; p.(Glu595Val)). The patient presented with early-onset global developmental delay, cerebellar ataxia, dysarthria, action tremor, and oculomotor abnormalities without epilepsy. Brain MRI showed marked hypoplasia of the inferior cerebellar vermis associated with a mega cisterna magna, without involvement of the cerebellar hemispheres. Follow-up over more than fifteen years showed relatively preserved functional autonomy in late adolescence (SARA 8.5/40; FARS-ADL 11/36). Western blot analysis of patient-derived fibroblasts revealed low but detectable BRAT1 protein levels (approximately 15–20% of mean control expression), indicating reduced but retained BRAT1 protein expression, compatible with, but not proof of, a residual-function effect.

Conclusions

These findings are compatible with a contribution of residual BRAT1 protein expression to phenotypic attenuation in this patient and further expand the mild end of the BRAT1-related disease spectrum. Functional assays performed on readily accessible patient material may improve the interpretation of rare variants in neurodevelopmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Association StudiesCell Cycle ProteinsNeurodevelopmental DisordersNuclear ProteinsHumansMaleAdolescentPhenotypeMagnetic Resonance ImagingMutation, MissenseNeurodevelopmentCerebellum

Stichwörter der Autor:innen

BRAT1 disease spectrumWestern blotcerebellar hypoplasiagait ataxianeurodevelopmental disordersskin punch biopsy

Substanzen

BRAT1 protein, humanCell Cycle ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Via dei Giacinti 2, 56128 Pisa, Italy.
  • Molecular Medicine, IRCCS Fondazione Stella Maris, 56128 Pisa, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
  • U.O.S. Dipartimentale e Servizio Autonomo di Risonanza Magnetica, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

ORCID-Profile: Camilla Meossi, Lorenzo Cipriano, Flavio Dal Canto, Stefano Pagano, Roberta Battini, Filippo M Santorelli

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

Meossi, C., Cipriano, L., Dal Canto, F., Pagano, S., Nutile, G., Tessa, A., Cona, C., Dalla Zanna, G., Battini, R., Montanaro, D., & Santorelli, F. M. (2026). A Mild Neurodevelopmental Phenotype Associated with a Novel BRAT1 Variant: Expanding Genotype–Phenotype Correlations. Medical Sciences. https://doi.org/10.3390/medsci14060641

Vancouver

Meossi C, Cipriano L, Dal Canto F, Pagano S, Nutile G, Tessa A, et al. A Mild Neurodevelopmental Phenotype Associated with a Novel BRAT1 Variant: Expanding Genotype–Phenotype Correlations. Medical Sciences. 2026. doi:10.3390/medsci14060641

BibTeX
@article{Meossi2026,
  author = {Meossi, Camilla and Cipriano, Lorenzo and Dal Canto, Flavio and Pagano, Stefano and Nutile, Giulia and Tessa, Alessandra and Cona, Carla and Dalla Zanna, Gianmarco and Battini, Roberta and Montanaro, Domenico and Santorelli, Filippo M},
  title = {A Mild Neurodevelopmental Phenotype Associated with a Novel BRAT1 Variant: Expanding Genotype–Phenotype Correlations},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14060641}
}
Kostenlos starten →